ストックスクリーナーアプリを入手
1.26
6.67%
-0.09
アフターアワーズ：
1.26
前日終値:
$1.35
開ける：
$1.38
24時間の取引高:
136.29K
Relative Volume:
0.31
時価総額：
$88.43M
収益：
-
当期純損益:
$-30.04M
株価収益率:
-0.7975
EPS:
-1.58
ネットキャッシュフロー:
$-27.38M
1週間 パフォーマンス:
-2.33%
1か月 パフォーマンス:
+2.44%
6か月 パフォーマンス:
-19.75%
1年 パフォーマンス:
-15.44%
1日の値動き範囲:
$1.26
$1.38
1週間の範囲:
$1.24
$1.42
52週間の値動き範囲:
$0.8301
$3.79
Regulus Therapeutics Inc Stock (RGLS) Company Profile
名前
Regulus Therapeutics Inc
セクター
電話
858-202-6300
住所
4224 CAMPUS POINT COURT, SAN DIEGO, CA
RGLS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RGLS
Regulus Therapeutics Inc
|
1.26 | 88.43M | 0 | -30.04M | -27.38M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Regulus Therapeutics Inc Stock (RGLS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-02 | 開始されました | Oppenheimer | Outperform |
| 2024-03-18 | 開始されました | Leerink Partners | Outperform |
| 2018-03-28 | 開始されました | B. Riley FBR, Inc. | Neutral |
| 2018-01-05 | 開始されました | Leerink Partners | Outperform |
| 2017-06-13 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-03-06 | 繰り返されました | Wedbush | Outperform |
| 2017-01-30 | ダウングレード | Needham | Buy → Hold |
| 2017-01-30 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2016-12-07 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-11-02 | 繰り返されました | Needham | Buy |
| 2016-07-25 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-06-28 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-06-28 | 繰り返されました | FBR Capital | Outperform |
| 2016-06-28 | 繰り返されました | Needham | Buy |
| 2016-06-07 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-04-13 | 開始されました | Chardan Capital Markets | Buy |
| 2015-12-04 | 開始されました | Wells Fargo | Outperform |
| 2015-06-09 | 開始されました | Guggenheim | Buy |
| 2015-04-21 | 再開されました | FBR Capital | Outperform |
| 2014-11-24 | 開始されました | Deutsche Bank | Buy |
| 2014-08-07 | 繰り返されました | FBR Capital | Outperform |
| 2013-08-14 | 繰り返されました | Needham | Buy |
すべてを表示
Regulus Therapeutics Inc (RGLS) 最新ニュース
Regulus Therapeutics’ (RGLS) Buy Rating Reiterated at HC Wainwright - Defense World
Promising Phase 1b Results and FDA Alignment Drive Buy Rating for Regulus Therapeutics - TipRanks
Regulus Therapeutics Inc. (RGLS): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey
10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average PT from Analysts - MarketBeat
Pre-market Movers In Healthcare Sector: ACER, AZRX, RUBY, ADTX, RGLS… - RTTNews
Checking in on Regulus Therapeutics Inc (RGLS) after recent insiders movement - Knox Daily
Is Regulus Therapeutics Inc (NASDAQ: RGLS) Stock Worth Investing In for High Returns? - Marketing Sentinel
RGLS’s price-to-free cash flow ratio: A closer look at its relevance - US Post News
Regulus Therapeutics Inc (RGLS) Stock: A Year of Highs and Lows - The InvestChronicle
Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Morningstar
Regulus Therapeutics Inc. (NASDAQ:RGLS) Director David Baltimore Acquires 19,610 Shares - MarketBeat
Insider Buying: Regulus Therapeutics Inc. (NASDAQ:RGLS) CEO Acquires 50,000 Shares of Stock - MarketBeat
JPMorgan Chase & Co. Raises Stake in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World
Insider Moves Spark Interest: Is Regulus Therapeutics Set for a Comeback? - Jomfruland.net
Insiders Give Up US$8.7k As Regulus Therapeutics Stock Drops To US$1.00 - Yahoo Finance
CEO & Director of Regulus Therapeutics Joseph Hagan Buys 24% More Shares - Simply Wall St
Insider Buying: David Baltimore Acquires Shares of Regulus Thera - GuruFocus.com
Insider Buying: Joseph Hagan Acquires 50,000 Shares of Regulus T - GuruFocus.com
Regulus stock tumbles 24% amid study, regulatory updates - MSN
REVB Start 1B Trial and Announces Split - MSN
Regulus Therapeutics Shares Drop 24% Despite Positive ADPKD Tria - GuruFocus.com
Regulus Therapeutics Shares Drop 24% Despite Positive ADPKD Trial Data - Yahoo Finance
Regulus Therapeutics Kidney Disease Treatment Shows Response in Early-stage Trial -- Shares Fall - Marketscreener.com
Regulus stock tumbles 24% amid study, regulatory updates (RGLS:NASDAQ) - Seeking Alpha
Regulus reports progress in ADPKD trial and FDA talks - MSN
Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429) - Citizentribune
Regulus Therapeutics (RGLS) Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen - StreetInsider.com
Regulus Therapeutics stock hits 52-week low at $1.16 - MSN
Regulus Therapeutics stock hits 52-week low at $1.16 By Investing.com - Investing.com South Africa
Barclays PLC Grows Stake in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World
Regulus Therapeutics CFO sells shares worth $55,333 By Investing.com - Investing.com South Africa
Jane Street Group LLC Takes $46,000 Position in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World
Regulus Therapeutics president sells $39,721 in stock By Investing.com - Investing.com Australia
Regulus Therapeutics CEO sells shares worth $160,494 By Investing.com - Investing.com Canada
Regulus therapeutics executive sells shares worth $55,119 By Investing.com - Investing.com Nigeria
Insider Selling: Regulus Therapeutics Inc. (NASDAQ:RGLS) Insider Sells 31,445 Shares of Stock - MarketBeat
Joseph P. Hagan Sells 115,290 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) Stock - MarketBeat
Christopher Ray Aker Sells 38,547 Shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) Stock - MarketBeat
Regulus Therapeutics Inc. (NASDAQ:RGLS) CFO Crispina Calsada Sells 38,716 Shares - MarketBeat
Regulus therapeutics executive sells shares worth $55,119 - Investing.com India
Regulus Therapeutics president sells $39,721 in stock - Investing.com
Regulus Therapeutics CFO sells shares worth $55,333 - Investing.com
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Consensus PT from Analysts - Defense World
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Geode Capital Management LLC Lowers Stock Holdings in Regulus Therapeutics Inc. (NASDAQ:RGLS) - Defense World
Regulus Therapeutics Inc. (NASDAQ:RGLS) Shares Acquired by Barclays PLC - Defense World
Regulus Therapeutics Inc. (NASDAQ:RGLS) Shares Acquired by State Street Corp - Defense World
This Biotech Wasted No Time Stealing The Premarket Show - MSN
Regulus Therapeutics Announces Completion of Enrollment in Secon - GuruFocus.com
Regulus Therapeutics Inc. (NASDAQ:RGLS) Receives $10.80 Average Target Price from Analysts - Defense World
Regulus Therapeutics Inc (RGLS) 財務データ
収益
当期純利益
現金流量
EPS
Regulus Therapeutics Inc (RGLS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| BALTIMORE DAVID | Director |
Jan 30 '25 |
Buy |
1.06 |
19,610 |
20,787 |
22,169 |
| Aker Christopher Ray | Sr. VP & General Counsel |
Jan 13 '25 |
Sale |
1.26 |
38,547 |
48,693 |
54,634 |
| Aker Christopher Ray | Sr. VP & General Counsel |
Jan 14 '25 |
Sale |
1.26 |
5,088 |
6,427 |
49,546 |
| Hagan Joseph P | Chief Executive Officer |
Jan 13 '25 |
Sale |
1.26 |
115,290 |
145,634 |
222,572 |
| Hagan Joseph P | Chief Executive Officer |
Jan 14 '25 |
Sale |
1.26 |
11,764 |
14,860 |
210,808 |
| CALSADA CRISPINA | Chief Financial Officer |
Jan 13 '25 |
Sale |
1.26 |
38,716 |
48,906 |
50,566 |
| CALSADA CRISPINA | Chief Financial Officer |
Jan 14 '25 |
Sale |
1.26 |
5,088 |
6,427 |
45,478 |
| Klassen Preston | President & Head of R & D |
Jan 13 '25 |
Sale |
1.26 |
31,445 |
39,721 |
36,055 |
| Collier Kathryn J | Director |
Jul 25 '24 |
Buy |
1.82 |
4,000 |
7,280 |
6,740 |
6.45%
1.23%
大文字化:
|
ボリューム (24 時間):